Helius Medical Technologies Inc Class A HSDT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $0.72
- Day Range
- $0.67–0.74
- 52-Week Range
- $0.65–9.89
- Bid/Ask
- $0.68 / $0.70
- Market Cap
- $2.43 Mil
- Volume/Avg
- 81,406 / 223,994
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.33
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 22
- Website
- https://www.heliusmedical.com
Valuation
|
Metric
|
HSDT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.34 |
Price/Sales | 1.33 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
HSDT
|
|---|---|
Quick Ratio | 3.43 |
Current Ratio | 4.20 |
Interest Coverage | — |
Quick Ratio
HSDT
Profitability
|
Metric
|
HSDT
|
|---|---|
Return on Assets (Normalized) | −120.60% |
Return on Equity (Normalized) | −276.63% |
Return on Invested Capital (Normalized) | −273.76% |
Return on Assets
HSDT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Prmfsqqs | Klhjdjg | $196.1 Bil | |||
| Stryker Corp
SYK
| Gqxfchkv | Bbb | $137.7 Bil | |||
| Boston Scientific Corp
BSX
| Krbphlpk | Wlnwyl | $122.3 Bil | |||
| Medtronic PLC
MDT
| Ynrlxlqvz | Grplsyy | $114.7 Bil | |||
| Edwards Lifesciences Corp
EW
| Dqpzybyz | Mxvbgt | $39.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Sdjm | Yfph | $29.1 Bil | |||
| DexCom Inc
DXCM
| Xlvlqyxdgj | Xrgm | $27.1 Bil | |||
| Steris PLC
STE
| Yzdxxryfy | Btxdjd | $23.3 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Dqxmjlyrj | Dtzm | $21.9 Bil | |||
| Insulet Corp
PODD
| Rbrfxjxvn | Fklqbld | $16.5 Bil |
United States